HEAVY Drug Patent Profile
✉ Email this page to a colleague
When do Heavy patents expire, and when can generic versions of Heavy launch?
Heavy is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in HEAVY is dibucaine hydrochloride. Additional details are available on the dibucaine hydrochloride profile page.
AI Research Assistant
Sample questions
- What is the 5 year forecast for HEAVY?
- What are the global sales for HEAVY?
- What is Average Wholesale Price for HEAVY?
Summary for HEAVY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEAVY at DailyMed |
![HEAVY drug patent expirations Drug patent expirations by year for HEAVY](/p/graph/s/t/HEAVY-patent-expirations.png)
US Patents and Regulatory Information for HEAVY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | HEAVY SOLUTION NUPERCAINE | dibucaine hydrochloride | INJECTABLE;INJECTION | 006203-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |